European Lifestyle Disorders Therapeutics Market
Frost & Sullivan
August 19, 2009 81 Pages - SKU: MC2523908
|
|
| This research service deals with market drivers, restraints, market trends, competitive structure, revenues and market attractiveness analysis of the European lifestyle disorders therapeutics market.
|
- 1. Executive Summary
- Executive Summary of European Lifestyle Disorders Therapeutics Market
- Overview of European Lifestyle Disorders Therapeutics Market
- 2. Research Methodology
- Objective and Scope
- Research Methodology
- Objective and Scope
- 3. Market Overview
- Introduction
- Disease Overview
- 4. Industry Challenges
- Industry Challenges of Lifestyle Disorders Therapeutics Market
- Key Industry Challenges
- 5. Market Engineering Research for Obesity Therapeutics Market
- Obesity Therapeutics Market
- Overview of Obesity
- Market Engineering Measurements
- Market Drivers
- Market Restraints
- Revenue Forecasts
- Competitive Structure
- Brand Analysis
- 6. Market Engineering Research for Erectile Dysfunction Therapeutics Market
- Erectile Dysfunction Therapeutics Market
- Overview of Erectile Dysfunction
- Current Treatments Available for Erectile Dysfunction
- Market Engineering Measurements
- Market Drivers
- Market Restraints
- Revenue Forecasts
- Competitive Structure
- Brand Analysis
- 7. Strategic Recommendations
- Market Engineering Recommendations
- Market Engineering Strategic Recommendations
- 8. Database of Key Industry Participants
- Key Industry Participants
- Major Participants
- 9. Appendix
- Decision Support Database Tables
- Prevalence of Cardiovascular Diseases
- Coronary Heart Disease Prevalence
- New Cases of Diabetes
- Prevalence of Obese Population
- Population with Hypertension
- List of Figures
- Chapter 4
- Impact of top five industry challenges in the European lifestyle disorders therapeutics market from 2009 to 2015
- Chapter 5
- Market drivers ranked in order of impact in the European obesity therapeutics market from 2009 to 2015
- Market restraints ranked in order of impact in the European obesity therapeutics market from 2009 to 2015
- Revenue forecasts for the European obesity therapeutics market from 2005 to 2015
- Competitive structure of the European obesity therapeutics market in 2008
- Available therapeutic drugs in the European obesity therapeutics market in 2008
- Pipeline drugs in development in the European obesity therapeutics market in 2008
- SWOT analysis of Reductil in the European obesity therapeutics market in 2008
- SWOT Analysis of Xenical in the European obesity therapeutics market in 2008
- Chapter 6
- Market drivers ranked in order of impact in the European erectile dysfunction therapeutics market from 2009 to 2015
- Market restraints ranked in order of impact in the European erectile dysfunction therapeutics market from 2009 to 2015
- Revenue forecasts for the European erectile dysfunction therapeutics market from 2005 to 2015
- Competitive structure of the European erectile dysfunction therapeutics market in 2008
- Available therapeutic drugs in the European erectile dysfunction therapeutics market in 2008
- Pipeline drugs in development in the European erectile dysfunction therapeutics market in 2008
- SWOT analysis of Viagra in the European erectile dysfunction therapeutics market in 2008
- SWOT analysis of Cialis in the European erectile dysfunction therapeutics market in 2008
- SWOT analysis of Levitra in the European erectile dysfunction therapeutics market in 2008
- Chapter 9
- Prevalence of cardiovascular diseases in million worldwide from 2002 to 2012
- Coronary heart disease in '000 worldwide from 2002 to 2012
- New cases of diabetes in '000 worldwide from 2002 to 2012
- Prevalence of obese population in million worldwide from 2004 to 2014
- Population with hypertension in million worldwide from 2002 to 2014
Share this report
Other tasks Related Markets Cardiovascular Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
